Natural sources as potential anti-cancer agents: A review
Keywords:
Cancer, vincristin, vinblastin, fruit, vegetablesAbstract
Natural products remain an important source of new drugs, new drug leads and new chemical entities. The plant based drug discovery resulted mainly in the development of anticancer agents including plants (vincristine, vinblastine, etoposide, paclitaxel, camptothecin, topotecan and irinotecan), marine organisms (citarabine, aplidine and dolastatin 10) and micro-organisms (dactinomycin, bleomycin and doxorubicin). Beside this there is numerous agents identified from fruits and vegetables can used in anticancer therapy. The agents include curcumin (turmeric), resveratrol (red grapes, peanuts and berries), genistein (soybean), diallyl sulfide (allium), S-allyl cysteine (allium), allicin (garlic), lycopene (tomato), capsaicin (red chilli), diosgenin (fenugreek), 6-gingerol (ginger), ellagic acid (pomegranate), ursolic acid (apple, pears, prunes), silymarin (milk thistle), anethol (anise, camphor, and fennel), catechins (green tea), eugenol (cloves), indole-3-carbinol (cruciferous vegetables), limonene (citrus fruits), beta carotene (carrots), and dietary fiber. In this review active principle derived from natural products are offering a great opportunity to evaluate not only totally new chemical classes of anticancer agents, but also novel lead compound and potentially relevant mechanisms of action.
References
Hail Jr N. Mitochondria: a novel target for
the chemoprevention of cancer. Apoptosis.
;10:687–705.
Aggarwal BB, Danda D, Gupta S, Gehlot P.
Models for prevention and treatment of
cancer: Problems vs promises. Biochem
Pharmacol. 2009;78:1083–1094.
Farnsworth NR. Ethnobotany and the Search
for New Drugs, Wiley Willett WC. Diet and
health: what should we eat. Science.
;264(5158):532–7.
Duraipandiyan V, Ayyanar M, Ignacimuthu
S. Antimicrobial activity of some
ethnomedicinal plants used by Paliyar tribe
from Tamil Nadu, India. BMC Comp Alter
Med. 2006;6:35-41.
Cragg GM, Kingston DGI, Newman DJ.
Anticancer Agents from Natural Products.
Taylor & Francis Group, Boca Raton, FL.
Brunner-Routledge Psychology Press; 2005.
Cragg GM, Newman D J, Weiss RB. Coral
reefs, forests, and thermal vents: the
worldwide exploration of nature for novel
antitumor agents. Semin Oncol.
;24:156-163.
Newman DJ, Cragg GM. Natural products as
sources of new drugs over the last 25 years. J
Nat Prod. 2007;70:461–477.
Butler MS. Natural products to drugs: natural
product derived compounds in clinical trials.
Nat Prod Rep. 2005;22:162–195.
Bailly C. Ready for a comeback of natural
products in oncology. Biochem Pharmacol.
;77:1447–1457.
Newman DJ, Cragg GM, Snader KM.
Natural products as sources of new drugs
over the period 1981–2002. J Nat Prod.
;66: 1022–1037.
Butler MS. The role of natural product
chemistry in drug discovery. J Nat Prod.
;67:2141–2153.
DeVita VT Jr, Serpick AA, Carbone PO.
Combination chemotherapy in the treatment
of advanced Hodgkin’s disease. Ann Intern
Med. 1970;73:881-895.
Noble RL. The discovery of the vinca
alkaloids – chemotherapeutic agents against
cancer. Biochem Cell Biol. 1990;68:1344-
Stähelin H. Actvity of a new glycosidic
lignan derivative (VP-16-213) related to
podophyllotoxin in experimental tumors. Eur
J Cancer. 1973;9:215-221.
Harvey AL. Medicines from nature: are
natural products still relevant to drug
discovery. Trends Pharmacol Sci.
;20:196-198.
Liu LF. DNA topoisomerase poisons as
antitumor drugs. Annu Rev Biochem.
;58:351-375.
Wani MC, Taylor HL, Wall ME, et al. Plant
antitumor agents. VI. The isolation and
structure of taxol, a novel antileukemic and
antitumor agent from Taxus brevifolia. J Am
Chem Soc. 1971;93:2325-2327.
Creemers GJ, Bolis G, Gore M, et al.
Topotecan, an active drug in the second-line
treatment of epithelial ovarian cancer. J Clin
Oncol. 1996;14:3056-3061.
Bertino JR. Irinotecan for colorectal cancer.
Semin Oncol. 1997;24:S18-S23.
Liu LF, Desai SD, Li TK, et al. Mechanism
of action of camptothecin. Ann New York
Acad Sci. 2000;922:1-10.
Harmon AD, Weiss U, Silverton JV. The
structure of rohutukine, the main alkaloid of
Amoora rohituka (syn. Aphanamixis
polystachya) (Maliaceae). Tetrahydron.
;20:721-724.
Cragg G, Suffness M. Metabolism of plantderived anticancer agents. Pharmacol Ther.
;37:425-432.
Losiewicz MD, Carlson BA, Kaur G, et al.
Potent inhibition of cdc2 kinase activity by
the flavonoid L86-8275. Biochem Biophys
Res Commun. 1994;201:589-595.
Worland PJ, Kaur G, Stetler-Stevenson M, et
al. Alteration of the phosphorylation state of
p32cdc2 kinase by the flavone L86-8275 in
breast carcinoma cells. Biochem Pharmacol.
;46:1831-1836.
Kelland LR. Flavopiridol, the first cyclindependent kinase inhibitor to enter the clinic:
current status. Ex Opin Inv Drugs.
;9:2903-2911.
Powell RG, Weisleder D, Smith CR Jr, et al.
Structures of harringtonine, isoharringtonine,
and homoharringtonine. Tetrahydron Lett.
;11:815-818.
Zhou DC, Zittoun R, Marie JP.
Homoharringtonine: an effective new natural
product in cancer chemotherapy. Bull
Cancer. 1995;82:987-995.
Kantarjian HM, O’Brien S, Anderlini P, et al.
Treatment of myelogenous leukemia: current
status and investigational options. Blood.
;87:3069-3081.
Rowinsky EK, Noe DA, Ettinger DS, et al.
PhaseI and pharmacological study of the
pulmonary cytotoxin 4-ipomeanol on a single
dose schedule in lung cancer patients:
hepatotoxicity is dose limiting in humans.
Cancer Res. 1993;53:1794-1801.
Rehm S, Devor DE. Acute effects of 4-
ipomeanol on experimental lung tumors with
bronchiolar or alveolar cell features in Syrian
hamsters or C3H/HeNCr mice. J Cancer Res
Clin Oncol. 1993;120:41-50.
Li YZ, Li CJ, Pinto AV, et al. Release of
mitochondrial cytochrome c in both
apoptosis and necrosis induced by β-
lapachone in human carcinoma cells. Mol
Med. 1999;4:232-239.
Vukovic-Gacic B, Nikcevic S, Beric-Bjedov
T, et al. Antimutagenic effect of essential oil
of sage (Salvia officinalis L.) and its
monoterpenes against UV-induced mutations
in Escherichia coli and Saccharomyces
cerevisiae. Food Chem Toxicol.
;44:1730–1738.
ÖnayUçar E, Karagöz A, Arda N.
Antioxidant activity of Viscum album sp.
Fitoterapia. 2006;77: 556–560.
Pinney KG, Jelinek C, Edvardsen K, et al.
The discovery and development of the
combretastatins. In: Cragg GM, Kingston
DGI, Newman DJ. Anticancer Agents from
Natural Products. Taylor & Francis Group,
Boca Raton, FL Brunner-Routledge
Psychology Press; 2005:23–46 (Chapter 3).
Evandri MG, Battinelli L, Daniele C, et al.
The antimutagenic activity of Lavandula
angustifolia (lavender) essential oil in the
bacterial reverse mutation assay. Food Chem
Toxicol. 2005;43:1381–1387.
Hwang BY, Su BN, Chai H, et al. Silvestrol
and episilvestrol, potential anticancer
rocaglate derivatives from Aglaia silvestris. J
Org Chem. 2004;69(10):3350-3358.
Cassady JM, Chan KK, Floss HG, et al.
Recent developments in the Maytansanoid
antitumor agents. Chem Pharma Bulletin.
;52:1–26.
Suffness M, Douros J. Miscellaneous natural
products with antitumor activity. In: Cassady
JM, Douros JD. Anticancer Agents Based on
Natural Product Models. New York ,
Academic Press; 1980:474 (Chapter 14).
Ravelo AG, Estevez-Braun A, ChavezOrellana H, et al. Recent studies on natural
products as anticancer agents. Curr Topics
Med Chem. 2004;4:241–265.
Jang DS, Park EJ, Hawthorne ME, et al.
Potential cancer chemopreventive
constituents of the seeds of Dipteryx odorata
(tonka bean). J Nat Prod. 2003;66(5):583–
Denmeade SR, Jakobsen CM, Janssen S, et
al. Prostate-specific antigen-activated
thapsigargin prodrug as targeted therapy for
prostate cancer. J Natl Cancer Inst.
;95:990–1000.
Newman DJ, Cragg GM, Holbeck S, et al.
Natural products as leads to cell cycle
pathway targets in cancer chemotherapy.
Curr Cancer Drug Targets. 2002;2:279–308.
Hernandez-Ceruelos A, Madrigal-Bujaidar E,
de la Cruz C. Inhibitory effect of chamomile
essential oil on the sister chromatid
exchanges induced by daunorubicin and
methyl methanesulfonate in mouse bone
marrow. Toxicol Lett. 2002;135:103–110.
Silva GL, Cui B, Chavez D, et al.
Modulation of the multidrug-resistance
phenotype by new tropane alkaloid aromatic
esters from Erythroxylum pervillei. J Nat
Prod. 2001;64(12):1514– 1520.
Lee D, Bhat KPL, Fong HHS, et al.
Aromatase inhibitors from Broussonetia
papyrifera. J Nat Prod. 2001;64(10):1286–
Marnewick JL, Gelderblom WCA, Joubert E.
An investigation on the antimutagenic
properties of South African herbal teas.
Mutat Res. 2000;471:157–166.
Abdulla M, Gruber P. Role of diet
modification in cancer prevention.
Biofactors. 2000;12:45– 51.
Dinkova-Kostova AT, Talalay P. Persuasive
evidence that quinine reductase type 1 (DT
diaphorase) protects cells against the toxicity
of electrophiles and reactive forms of
oxygen. Free Radic Biol Med. 2000;29(3–4):
–240.
Sausville EA, Zaharevitz D, Gussio Z, et al.
Cyclin-dependent kinases: initial approaches
to exploit a novel therapeutic target.
Pharmacol Thera. 1999;82:285.
He K, Valcic S, Timmerman BN, et al.
Indole alkaloids from Aristotelia chilensis
(Mol.) Stuntz. Int J Pharmacog.
;35:215–217.
Khamis SB, Brown JE, Bibby MC, et al.
Evaluation of two plants species used in
Malay traditional medicine for the treatment
of breast cancer. J Pharma Pharmacol.
;49:113.
Liang HR, Vuorela P, Vuorela H, et al.
Isolation and immunomodulatory effect of
flavonol glycosides from Epimedium
hunanense. Planta Medica. 1997;63:316 –
Peres MTLP, Monache FD, Cruz AB, et al.
Chemical composition and antimicrobial
activity of Croton urucurana Baillon
(Euphorbiaceae). J Ethnopharmacol.
;56:223 – 226.
Barakat HH, Hussein SAM, Marzour MS, et
al. Polyphenolic metabolites of Epilobium
hersutum. Phytochemistry. 1997;46:935–941.
Bai L, Yamaki M, Takagi S. Lignans and a
bichroman from Pleione bulbocodioides.
Phytochemistry. 1997;44:341–343.
Jang M, Cai L, Udeani GO, et al. Cancer
chemopreventive activity of resveratrol, a
natural product derived from grapes. Science.
;275(5297):218– 220.
Gupta MP, Monge A, Karikas GA, et al.
Screening of Panamanian medicinal plants
for brine shrimp toxicity, crown gall tumor
inhibition, cytotoxicity and DNA
intercalation. Int J Pharmacog. 1996;34:19 –
Suh HW, Song DK, Son KH, et al.
Antinociceptive effect of Smilaxin B
administered intracerebroventricularly in the
mouse. Planta Med. 1996;62:141 – 145.
Shirota O, Tamemura T, Morita H, et al.
Triterpenes from Brazilian medicinal plant
‘‘Chuchuhuasi’’ (Maytenus krukobii ). J Nat
Prod. 1996;59:1072–1075.
Tsui WY, Brown GD. Cycloeudesmanolides
from Sarcandra glabra. Phytochemistry.
;43:819–821.
Um SH, Lee KR, Zee OP, Pyo S. The effect
of Salvia plebeia on murine macrophagemediated cytotoxicity. Nat Prod Sci. 1996;2:
– 47.
Ducki S, Hadfield JA, Lawrence CY, et al.
Isolation of E-1-(4’-hydroxyphenyl)-But-1-
en-3-one from Scutellaria barbata. Planta
Med. 1996;62:185–186.
Palomino E, Maldonado C, Kempff MB, et
al. Caparratriene, an active sesquiterpene
hydrocarbon from Ocotea caparrapi. J Nat
Prod. 1996;59:77 – 79.
Singh VK, Ali ZA, Zaidi STH, et al.
Ethnomedicinal uses of plants of Gonda
district forests of Uttar Pradesh, India.
Fitoterapia. 1996;67:129 – 139.
Flores JS, Ricalde RV. The secretions and
exudates of plants used in mayan traditional
medicine. J Herbs Spices Med Plants.
;4:53–59.
Ahn BT, Oh KJ, Ro JS, Lee KS. A new
flavonoid from Euphorbia ebracteolata.
Planta Med. 1996;62:383–384.
Hu K, Dong A, Yao XS, et al. Antineoplastic
agents I. Three spirostanol glycosides from
rhizomes of Dioscorea collettii var.
hypoglauca. Planta Med. 1996;62:573 – 575.
Joe YK., Son JK, Park SH, et al. New
naphthalenyl glucosides from the roots of
Juglans mandshurica. J Nat Prod.
;59:159 – 160.
Zeng, JF, Li GL, Zhu DY. Two isoprenoidsubsititued isoflavans from roots of Maackia
tenuifolia. Phytochemistry. 1996;43:893 –
Martinez-Lirola MJ, Gonzalez-Tejero MR,
Molero-Mesa J. Ethnobotanical resources in
the province of Almeria, Spain, Campos De
Nijar. Econ Bot. 1996;50:40 – 56.
Peng JN, Feng XZ, Liang XT. A new Iridoid
from Hedyotis crysotrichae. Chin Chem Lett.
;6:965–966.
Ducki S, Hadfield JA, Lawrence NJ, et al.
Isolation of paeonol from Arisaema
eubescens. Planta Med. 1995;61:586–587.
Aquino R, Pizza C, De Tommasi N, et al.
New polyoxypregnane ester derivatives from
Leptadenia hastata. J Nat Prod. 1995;58:67.
Tiwari VJ. Ethnobotanical survey of Halbi
tribe of Chandrapur and Gadchiroli districts
of Maharashtra State, India. Fitoterapia.
;66:346 – 350.
Rabi T, Gupta RC. Antitumor and cytotoxic
investigation of Amoora rohituka. Int J
Pharmacog. 1995;33:359–361.
Ho LK, Ou JC, Sun ML, Sun CM. Two rare
alkaloids from Pratia nummularia. Planta
Med. 1995;61:567–568.
Rivera D, Obon C. The Ethnopharmacology
of Madeira and Porto Santo islands, a review.
J Ethnopharmacol. 1995;46:73–93.
Shirota O, Morita H, Takeya K, Itokawa H.
Structures of xuxuarines, stereoisomeric
triterpene dimmers from Maytenus
chuchuhuasca. Tetrahedron. 1995;51:1107–
Fujita T, Sezik E, Tabata M, et al. Traditional
medicine in Turkey VII. Folk medicine in
middle and west Black sea regions. Econ
Bot. 1995;49:406–422.
Shi JG, Jia ZJ, Cui YX. Novel Tricyclic
Diterpenoids from Euphorbia micractina. J
Nat Prod. 1995;58:51–56.
Wu DG, Sorg B, Hecker E. New myrsinolrelated polyfunctional pentacyclic diterpene
esters from roots of Euphorbia prolifera. J
Nat Prod. 1995;58:408–413.
Gonzalez-Tejero MR, Molero-Mesa J,
Casares-Porcel M, et al. New Contributions
to the ethnopharmacology of Spain. J
Ethnopharmacol. 1995;45:157–163.
Ahmad FB, Holdsworth DK. Traditional
medicinal plants of Sabah, Malaysia part III.
The Rungus people of Kudat. Int J
Pharmacog. 1995;33:262–264.
Amusan OOG, Msonthi JD, Makhubu LP.
Molluscicidal activity of Spathodea
campanulata, Andrachneovalis,
Phytolacca dodecandra and Hypoxis rooperi.
Fitoterapia. 1995;66:113–116.
Zani CL, Chaves PPG, Queiroz R, et al.
Brine shrimp lethality assay as a
prescreening system for anti-trypanosoma
cruzi activity. Phytomedicine. 1995;2:47–50.
Pisha E, Chai H, Lee IS, et al. Discovery of
betulinic acid as a selective inhibitor of
human melanoma that functions by induction
of apoptosis. Nat Med. 1995;1(10):1046–
Laferriere JE. Medicinal plants of the
lowland Inga people of Colombia. Int J
Pharmacog. 1994;32:90– 4.
Lin LZ, Hu SF, Zaw K, et al. Thalifaberidine,
a cytotoxic aporphine-benzylisoquinoline
alkaloid from Thalictrum faberi. J Nat Prod.
;57:1430– 1436.
Bae K H, Min BS, Park KI, Ahn BZ.
Cytotoxic flavonoids from Scutellaria indica.
Planta Med. 1994;60:280–281.
Ishiguro K, Nagata S, Fukumoto H, et al. A
-pyrone derivative from Hypericum
japonicum. Phytochemistry. 1994;37:283–
Chiang HC, Juilo Y, Lu FJ. Xanthine oxidase
inhibitors from the leaves of Alsophila
spinulosa (Hook) Tryon. J Enzyme Inhib.
;8:61–71.
Wu JB, Cheng YD, Kuo SC, et al.
Fissoldhimine, a novel skeleton alkaloid
from Fissistigma oldhamii. Chem Pharm
Bulletin. 1994;42:2202–2204.
Pinto DCG, Fuzzati N, Pazmino XC,
Hostettmann K. Xanthone and antifungal
constituents from Monnina obtusifolia.
Phytochemistry. 1994;37:875–878.
Liu WK, Ng TG, Sze SF, Tsui KW.
Activation of peritoneal macrophages by
polysaccharopeptide from the mushroom,
Coriolus 6ersicolor. Immunopharmacology.
;26:139–146.
Mohandoss S, Ravindran P. Flavonoids from
Melastoma melabathricum. Fitoterapia.
;64:277– 278.
Hammer M L A, Johns EA. Tapping an
Amazonian plethora, four medicinal plants of
Marajo Island, Para (Brazil). J
Ethnopharmacol. 1993;40:53-75.
Segura-Correa R, Mata R, Anaya AL, et al.
New tetranortriterpenoids from Swietenia
humilis. J Nat Prod. 1993;56:1567–1574.
Ghazanfar SA, Al-Sabahi MA. Medicinal
plants of Northern and Central Oman
(Arabia). Econ Bot. 1993;47:89– 98.
Cai Y, Chen JP, Phllipson J. Diterpenes from
Croton lechleri. Phytochemistry.
;32:755–760.
Hussain SJ, Alvi AB, Jahan M. A study on
Unani medicinal plants, Asteratiqus. J Res
Educ Indian Med. 1993;2:35–39.
Lin CC, Lin CH. Pharmacological and
pathological studies on Taiwan folk
medicine. IX. The hepatoprotective effect of
the methanolic extract from Echinops grijisii.
Am J Chin Med. 1993;21:33– 44.
Omino EA, Kokwaro JO. Ethnobotany of
Apocynaceae species in Kenya. J
Ethnopharmacol. 1993;40:167–180.
Rehm S, Devor DE. Acute effects of 4-
ipomeanol on experimental lung tumors with
bronchiolar or alveolar cell features in Syrian
hamsters or C3H/HeNCr mice. J. Cancer Res
Clin Oncol. 1993;120:41-50.
Stuppner H, Sturm S, Geisen G, et al. A
differential sensitivity of oxindole alkaloids
to normal and leukemic cell lines. Planta
Med. 1993;supplement A:583.
Holdsworth DK. A preliminary study of
medicinal plants of Easter Island, South
Pacific. Int J Pharmacog. 1992;30:27–32.
Sun HD, Zhou QZ, Fujita T, et al.
Rubescensin D, a diterpenoid from Rabdosia
rubescens. Phytochemistry. 1992;31:1418–
Qian TX, Li LN. Isosalvianolic acid C, a
depside possessing a dibenzooxepin skeleton.
Phytochemistry. 1992;31:1068–1070.
Furusawa E, Chou SC, Furusawa S, et al.
Antitumour activity of Ganoderma lucidum,
an edible mushroom, on intraperitoneally
implanted lewis lung carcinoma in
synergenic mice. Phytother Res. 1992;6:300
– 304.
Ding YL, Jia ZA. Two phenolic derivatives
from Euphorbia kansui. Phytochemistry.
;31:1435 – 1436.
Lin CC, Lin CH, Chiu HF, et al. The
Pharmacological and pathological studies on
Taiwan folk medicine (VII). The antiinflammatory effect of Echinops grjiisii. Am
J Chin Med. 1992;22:127 – 134.
De Feo V, Aquino R, Menghini A, et al.
Traditional phytotherapy in the peninsula
Sorrentina, Campania, Southern Italy. J
Ethnopharmacol. 1992;36:113 – 125.
Wong BYY, Lau BHS, Teel RW. Chinese
medicinal herbs modulated mutagenesis,
DNA binding and metabolism of
Benzo[A]Pyrene. Phytother Res. 1992;6:10 –
Hua YY. Two new saponins from the roots
of Phytolacca esculenta. Planta Med.
;58:99 – 101.
Sakagami H, Konno K, Kawazoe Y, et al.
Multiple immunological functions of extract
from the cone of Japanese white pine, Pinus
par6iflora Sieb. et Zucc. Adv Exp Med Biol.
;319:331 – 335.
Kao WJ, Hung DZ, Tsai WJ, et al.
Podophyllotoxin intoxication. Toxic effect of
Bajiaolian in herbal therapeutics. Hum Exp
Toxicol. 1992;11:480 – 487.
Lee IR, Song JY, Lee YS. Cytotoxicity of
folkloric medicines in murine and human
cancer cells. Kor J Pharmacog. 1992;23:132
– 136.
Reddy MB, Reddy KR, Reddy MN.
Ethnobotany of Cuddapah district, Andhra
Pradesh, India. Int J Pharmacog. 1991;29:273
– 280.
Chhabra SC, Mahunnah RLA, Mshiu MN.
Plants used in traditional medicine in Eastern
Tanzania. V. Angiosperms (Passifloraceae to
Sapindaceae). J Ethnopharmacol.
;33:143 – 157.
Holdsworth DK. Traditional medicinal plants
of Rarotonga, Cook Islands. Part II. Int J
Pharmacog. 1991;29:71– 79.
Kijjoa A, Gonzalez MJTG, Pinto MMM, et
al. Constituents of Knema laurina and Knema
tenuiner6ia subsp. setosa. Planta Med.
;57:575– 577.
Sati OP, Bahuguna S, Uniyal S, et al. A new
saponin from Deeringia amaranthoides. J Nat
Prod. 1990;53:466–469.
Konda Y, Iguchi M, Harigaya Y, et al.
Hancokinol, a novel triterpene, from
Cynanchum hancokianum. Tetrahedron Lett.
;31:5315 – 5318.
Bhat RB, Eterjere EO, Oladipo VT.
Ethnobotanical studies from Central Nigeria.
Econ Bot. 1990;44:382 – 390.
Plotkin MJ, Schultes RE. Virola, a promising
genus for ethnopharmacological
investigation. J Psychoactive Drugs.
;22:357–361.
Novaretti R, Lemordant D. Plants in the
traditional medicine of the Ubaye valley. J
Ethnopharmacol. 1990;30:1– 34.
Uniyal MR. Utility of hitherto unknown
medicinal plants traditionally used in
Ladakh. J Res Educ Indian Med. 1990;9:89 –
Vinesi P, Serafini M, Nicoletti M, et al. Plant
regeneration and hypoxoside content in
Hypoxis obtusa. J Nat Prod. 1990;53:196 –
Chu DT, Wong WL, Mavlight GM.
Immunotherapy with Chinese medicinal
herbs: immune restoration of local xenogenic
graft-versus-host reaction in cancer patients
by fractionated Astragalus membranacueus in
vitro. J Clin Lab Immunol. 1988;25(3):19-23.
Kokwaro JO. Medicinal plants of east Africa.
East African Literature Bureau,
Nairobi;1976.
Powell RG, Weisleder D, Smith CRJr, et al.
Structures of harringtonine, isoharringtonine,
and homoharringtonine. Tetrahydron Lett.
;11: 815-818.
Block G, Patterson B, Subar A. Fruit,
vegetables, and cancer prevention: a review
of the epidemiological evidence. Nutr
Cancer. 1992;18(1):1–29.
Steinmetz KA, Potter JD. Vegetables, fruit,
and cancer prevention: a review. J Am Diet
Assoc. 1996;96(10):1027–39.
Reddy L, Odhav B, Bhoola KD. Natural
products for cancer prevention: a global
perspective. Pharmacol Ther. 2003;99(1):1–
Aggarwal BB, Shishodia S. Molecular
targets of dietary agents for prevention and
therapy of cancer. Biochem Pharmacol.
;71:1397–1421.
Hoyoku N, Michiaki M, Harukuni T, et al.
Cancer prevention by carotenoids. Arch
Biochem Biophys. 2009;483:(2):165-168.
Wan X, Luo M, Li X, et al. Hepatoprotective
and anti-hepatocarcinogenic effects of
glycyrrhizin and matrine. Chem Biol
Interact. 2009;181:(1)15-19.
Caihua L, Michael DMc, Carmen M, et al. A
Population-Based Case-Control Study of
Marijuana Use and Head and Neck
Squamous Cell Carcinoma. Cancer Prev Res.
;2(8):759-768.
Shiu-Chen H, Chi-Tang H, Shoei-Yn L, et al.
Carnosol inhibits the invasion of B16/F10
mouse melanoma cells by suppressing
metalloproteinase-9 through down-regulating
nuclear factor-kappa B and c-Jun. Biochem
Pharmacol. 2005;69(2):221-232.
Li M, Zhang Z, Hill DL, et al. Genistein, a
dietary isoflavone, down-regulates the
MDM2 oncogene at both transcriptional and
posttranslational levels. Cancer Res.
;65(18):8200–8.
Ruiz D, Egea J, Tomas-Barberan FA, et al.
Carotenoids from new apricot (Prunus
armeniaca L.) varieties and their relationship
with flesh and skin color. J Agric Food
Chem. 2005;53:6368-74.
Kim GY, Kim JH, Ahn SC, et al. Lycopene
suppresses the lipopolysaccharide-induced
phenotypic and functional maturation of
murine dendritic cells through inhibition of
mitogen-activated protein kinases and
nuclear factor-kappaB. Immunology.
;113(2):203–11.
Sunila ES, Kuttan G. Immunomodulatory
and antitumor activity of Piper longum Linn.
and piperine. J Ethnopharmacol. 2004;90:(2-
:339-346.
Shishodia S, Majumdar S, Banerjee S, et al.
Ursolic acid inhibits nuclear factor-kappaB
activation induced by carcinogenic agents
through suppression of IkappaBalpha kinase
and p65 phosphorylation: correlation with
downregulation of cyclooxygenase 2, matrix
metalloproteinase 9, and cyclin D1. Cancer
Res. 2003;63(15):4375–83.
Takada Y, Aggarwal BB. Betulinic acid
suppresses carcinogen-induced NF-kappa B
activation through inhibition of I kappa B
alpha kinase and p65 phosphorylation:
abrogation of cyclooxygenase-2 and matrix
metalloprotease-9. J Immunol.
;171(6):3278–86.
Cheng YH., Shen TF, Pang VF, et al. Effects
of aflatoxin and carotenoids on growth
performance and immune response in mule
ducklings. Comp Biochem Physiol Toxicol
Pharmacol. 1999;128:19– 26.
Abdullaev FI. Cancer chemopreventive and
tumoricidal properties of saffron (Crocus
sativus L.). Exp Biol Med. 2002;227:20-5.
Kohno H, Marda M, Honjo S. Prevention of
colonic preneoplastic lesions by the betacryptoxanthine and hesperidine rich powder
prepared from Citrus Unshiu Marc. Juice in
male F344 rats. J Toxicol Pathol.
;12:209-215.
Han SS, Keum YS, Seo HJ, et al. Capsaicin
suppresses phorbol ester-induced activation
of NF-kappaB/Rel and AP-1 transcription
factors in mouse epidermis. Cancer Lett.
;164(2):119–26.
Yang F, Oz HS, Barve S, et al. The green tea
polyphenol (-)-epigallocatechin-3-gallate
blocks nuclear factor-kappa B activation by
inhibiting I kappa B kinase activity in the
intestinal epithelial cell line IEC-6. Mol
Pharmacol. 2001;60(3):528–33.
Manna SK, Mukhopadhyay A, Aggarwal
BB. Resveratrol suppresses TNF-induced
activation of nuclear transcription factors
NF-kappa B, activator protein-1, and
apoptosis: potential role of reactive oxygen
intermediates and lipid peroxidation. J
Immunol. 2000;164(12):6509–19.
Cheng YH, Shen TF, Pang VF, et al. Effects
of aflatoxin and carotenoids on growth
performance and immune response in mule
ducklings. Comp Biochem Physiol Toxicol
Pharmacol. 1999;128:19– 26.
Berkarda B, Koyuncu H, Soybir GT, et al.
Inhibitory effect of hesperidin on tumor
initiation and promotion in mouse skin. Res
Exp Med. 1998;198:93-99.
Laughton MJ, Evans PJ, Moroney MA, et al.
Inhibition of mammalian 5-lipoxygenase and
cyclooxygenase by flavonoids and phenolic
dietary additives. Relationship to antioxidant
activity and to iron ionreducing ability.
Biochem Pharmacol. 1991;42(9):1673–81.
Soliman KF, Mazzio EA. In vitro attenuation
of nitric oxide production in C6 astrocyte cell
culture by various dietary compounds. Proc
Soc Exp Biol Med. 1998;218(4):390–7.
Kumar A, Dhawan S, Aggarwal BB. Emodin
(3-methyl-1,6,8-trihydroxyanthraquinone)
inhibits TNF-induced NFkappaB activation,
IkappaB degradation, and expression of cell
surface adhesion proteins in human vascular
endothelial cells. Oncogene. 1998;17(7):913–
Geng Z, Rong Y, Lau BH. S-Allyl cysteine
inhibits activation of nuclear factor kappa B
in human T cells. Free Radic Biol Med.
;23(2):345–50.
Sueoka N, Sueoka E, Okabe S, et al. Anticancer effects of morphine through inhibition
of tumour necrosis factor-a release and
mRNA expression. Carcinogenesis.
;17(11):2337-2341.
Kune GA, Bannerman S, Field B, et al. Diet,
smoking, serum beta-carotene and vitamin A
in male nonmelanocytic skin cancer patients
and controls. Nutr Cancer. 1992;18(3):237.
Gogate SS. Cytotoxicity of neem leaf
extract: an antitumor. Natl Med J India.
;9:297.
Pomponi AS. The bioprocess-technological
potential of the sea. J Biotechnol. 1999;70:5-
Schwartsmann G. Marine organisms and
other novel natural sources of new anticancer
drugs. Ann Oncol. 2000;11:235-243.
Schwartsmann G, Rocha AB, Berlinck R, et
al. Marine organisms as a source of new
anticancer agents. Lancet Oncol. 2001;2:221-
Schweitzer J, Handley FG, Edwards J, et al.
Summary of the workshop on drug
development, biological diversity, and
economic growth. J Natl Cancer Inst.
;83:1294-1298.
Rinehart KL. Antitumor compounds from
tunicates. Med Res Rev. 2000;20:1-27.
Chun HG, Davies B, Hoth D, et al.Suffness.
Didemnin B The first marine compound
entering clinical trials as an antineoplastic
agent. Invest New Drugs. 1986;4:279-284.
Geldof AA, Mastbergen SC, Henrar REC, et
al. Cytotoxicity and neurocytoxicity of new
marine anticancer agents evaluated using
invitro assays. Cancer Chemother Pharmacol.
;44:312-318.
Demetri G, Garcia-Carbonero R, Harmon D,
et al. Ecteinascidin-743 (ET-743) induces
objective responses and disease control in
patients with advanced non-osseous
sarcomas: results from phaseII trials. Ann
Oncol. 2000;11(Suppl 4):126.
Erba E, Bergamaschi D, Bassano L, et al.
Ecteinascidin-743 (ET-743), a natural marine
compound, with a unique mechanism of
action. Eur J Cancer. 2001;37:97-105.
Damia G, Silvestri S, Carrassa L, et al.
Unique pattern of ET-743 activity in different
cellular systems with defined deficiencies in
DNA-repair pathways. Int J Cancer.
;92:583-588.
Poncet J. The dolastatins, a family of
promising antineoplastic agents. Curr Pharm
Des. 1999;5:139-162.
Bai R, Pettit GR, Hamel E. Dolastatin10, a
powerful cytostatic peptide derived from a
marine animal. Inhibition of tubulin
polymerization mediated through the vinca
alkaloid binding domain. Biochem
Pharmacol. 1990;39:1941-1949.
Pathak S, Multani AS, Ozen M, et al.
Dolastatin10 induces polyploidy, telomeric
associations and apoptosis in a murine
melanoma cell line. Oncol Res. 1998;5:373-
Pettit GR. The bryostatins. Fortschr Chem
Org Naturst. 1991;57:153-195.
Pagliaro L, Daliani D, Amato R, et al. Phase
II trial of bryostatin-1 for patients with
metastatic renal cell carcinoma. Cancer.
;89:615-618.
Varterasian ML, Mohammad RM, Shurafa
MS, et al. PhaseII trial of bryostatin1 in
patients with relapsed low-grade nonHodgkin’s lymphoma and chronic
lymphocytic leukemia. Clin Cancer Res.
;6:825-828.
Zonder JA, Shields AF, Zalupski M, et al. A
phase II trial of bryostatin 1 in the treatment
of metastatic colorectal cancer. Clin Cancer
Res. 2001;7:38-42.
Ahmad I, Al-Katib AM, Beck FW, et al.
Sequential treatment of a resistant chronic
lymphocytic leukemia patient with
bryostatin1 followed by 2-
chlorodeoxyadenoside: case report. Clin
Cancer Res. 2000;6:1328-1332.
Mayer A and Gustafson KR. Marine
pharmacology in 2002–2004: Anti-tumour
and cytotoxic compounds. Eur J Cancer.
;42:2241–2270.
Mayer A and Gustafson K R. Marine
pharmacology in 2005–2006: Anti-tumour
and cytotoxic compounds. Eur J Cancer.
;44: 2257–2287.
Binaschi M, Farinosi R, Borgnetto ME, et al.
In vivo site specificity and human isoenzyme
selectivity of two topoisomerase II poisoning
anthracyclines. Cancer Res. 2000;60:3770-
Patrick Y. Major microbial diversity
initiative recommended. Am Soc Microbiol
News. 1997;63:417-421.
Alberts MW, Williams RT, Brown EJ, et al.
KBP-Rapamycin inhibits a cyclin-dependent
kinase activity and a cyclin D1-Cdk
association in early Gl of an osteosarcoma
cell line. J Biol Chem. 1993;268:22825-
Schulte TW, Neckers LM. The benzoquinone
ansamycin 17-allylamino-17
demethoxygeldanamycin binds to HSP90 and
shares important biologic activities with
geldanamycin. Cancer Chemother Harmacol.
;42:273-279.
Cadenas ME, Sandfrison A, Cutler NS, et al.
Signal transduction cascades as targets for
therapeutic intervention by natural products.
Trends Biotechnol. 1998;16:427-433.
Adjei AA. Signal transduction pathway
targets for anticancer drug discovery. Curr
Pharmaceut Design. 2000;6:361-378.
